<DOC>
	<DOCNO>NCT00580853</DOCNO>
	<brief_summary>The purpose study examine smoke cessation medication ( varenicline , bupropion ) affect ability resist smoking also subsequent ad-lib smoking non-treatment seek daily smoker .</brief_summary>
	<brief_title>The Effect Varenicline ( Chantix ) Bupropion ( Zyban ) Smoking Lapse Behavior</brief_title>
	<detailed_description />
	<mesh_term>Varenicline</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>age 1855 able read write English Smokers significant current medical psychiatric condition would contraindicate smoking current Diagnostic Statistical Manual IV abuse dependence substance , nicotine dependence alcohol abuse positive test result intake appointment urine drug screen conduct opiate , cocaine , benzodiazepine woman pregnant nursing suicidal , homicidal , evidence current severe mental illness participant prescribe psychotropic drug 30 day prior study enrollment blood donation within past 6 week individual seek treatment smoke cessation attempt quit smoking within past 3 month specific exclusion bupropion administration already specify , include : take monoamine inhibitor past 6 week ; history anorexia bulimia ; previous hypersensitivity bupropion ; history alcohol drug dependence past year ; history seizure disorder etiology know allergy varenicline take H2blockers participation within past 8 week study involve additive blood sample and/or interventional measure would consider excessive combination current study</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>smoke lapse behavior</keyword>
	<keyword>smoke cessation</keyword>
	<keyword>varenicline</keyword>
	<keyword>bupropion</keyword>
	<keyword>medication effect smoke lapse behavior</keyword>
</DOC>